biotech investing BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
biotech investing Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
biotech investing Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
biotech investing BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference
NevGold Announces Positive, Consistent Drill Results on Historic Gold Leach Pads Including 0.34% Antimony And 0.41 g/t Au Over 12.5 Meters; Path to Near-Term Antimony Production Continues
Domestic Metals Announces Closing of Final Tranche of Private Placement and Announces $7.0 million Financing
CHARBONE devoile son plan strategique 2026-2030 : une transformation vers un groupe integre de gaz industriels a haute valeur
CHARBONE Unveils its 2026-2030 Strategic Plan: A Transformation Towards an Integrated High-Value Industrial Gas Group
